Astrana Health (NASDAQ:ASTH) Reaches New 52-Week Low - What's Next?

Key Points

• Astrana Health shares have hit a new 52-week low, trading as low as $22.25, with a significant trading volume of 161,931 shares.
• The company reported earnings of $0.14 per share for the last quarter, which was below the consensus estimate of $0.23, and their revenue was 53.4% higher year-over-year but still fell short of analysts' projections.
• Institutional investors have increased their stakes in Astrana Health, with ownership now at 52.77% of the company’s stock, reflecting growing confidence among large shareholders.

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $22.25 and last traded at $22.37, with a volume of 161931 shares changing hands. The stock had previously closed at $23.86.

Astrana Health Price Performance

The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70. The company's 50-day simple moving average is $24.55 and its 200-day simple moving average is $29.46. The company has a market cap of $1.28 billion, a price-to-earnings ratio of 31.41, a P/E/G ratio of 0.79 and a beta of 0.85.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The firm had revenue of $620.39 million for the quarter, compared to analyst estimates of $628.11 million. During the same period in the previous year, the firm earned $0.31 earnings per share. Astrana Health's revenue was up 53.4% on a year-over-year basis. On average, equities research analysts anticipate that Astrana Health, Inc. will post 1.15 EPS for the current year.

Institutional Trading of Astrana Health

Institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Astrana Health by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 4,685,959 shares of the company's stock worth $147,748,000 after purchasing an additional 20,757 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Astrana Health by 136.1% in the fourth quarter. JPMorgan Chase & Co. now owns 163,532 shares of the company's stock worth $5,156,000 after purchasing an additional 94,268 shares in the last quarter. Pictet Asset Management Holding SA boosted its stake in Astrana Health by 21.9% in the fourth quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock worth $223,000 after purchasing an additional 1,273 shares in the last quarter. ExodusPoint Capital Management LP acquired a new position in Astrana Health in the fourth quarter worth $1,140,000. Finally, Wells Fargo & Company MN boosted its stake in Astrana Health by 41.5% in the fourth quarter. Wells Fargo & Company MN now owns 22,484 shares of the company's stock worth $709,000 after purchasing an additional 6,596 shares in the last quarter. Institutional investors and hedge funds own 52.77% of the company's stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.